Skip to main content
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.868
-0.022 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.850
-0.018 (-2.04%)
Pre-market: Apr 29, 2026, 7:50 AM EDT

RANI Revenue

In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth. Rani Therapeutics Holdings had revenue of $1.46M in the quarter ending December 31, 2025, with 42.12% growth.

Revenue (ttm)
$1.63M
Revenue Growth
+58.85%
P/S Ratio
53.05
Revenue / Employee
$23,000
Employees
71
Market Cap
86.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.63M605.00K58.85%
Dec 31, 20241.03M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 20212.72M2.26M488.10%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Q32 Bio 53.74M
Gossamer Bio 48.47M
Sangamo Therapeutics 39.55M
Pelthos Therapeutics 16.80M
NeurAxis 3.57M
eXoZymes -700.00
Revenue Rankings

RANI News

More News